News

FDA’s early AI debut sparks questions
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to ...
Nextgov1h
FDA unveils ‘Elsa’ generative AI tool for staff
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...
Fierce Biotech1h
FDA, facing 4% budget cut, launches generative AI tool Elsa a month ahead of schedule
The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency ...
Targeted Oncology49m
FDA Grants Priority Review to NDA of Ziftomenib in NPM1-Mutant AML
If approved, ziftomenib could be the first FDA-approved Menin inhibitor for relapsed/refractory acute myeloid leukemia with ...
US FDA launches AI tool to reduce time taken for scientific reviews
The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...
FDA authorizes AI tool to predict breast cancer risk
Senior medical analyst Dr. Marc Siegel discusses advancements in artificial intelligence aimed at predicting an individual's future risk of breast cancer and the increased health risks from cannabis ...
KSL3h
FDA launches AI tool to reduce time taken for scientific reviews
The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...
FDA commissioner commits to review of abortion pill
The Food and Drug Administration will conduct a review of the abortion pill mifepristone following intense pressure from Sen.